3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Terminated
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Plasma cell
1
Other hematologic neoplasm
1
Myeloid
1
Lymphoid
1
Conditions
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2
Multiple Myeloma
2
Leukemia, Myeloid, Acute
2
Waldenstrom Macroglobulinemia
1
Vulvar Neoplasms
1
Vaginal Neoplasms
1
Uterine Neoplasms
1
Uterine Cervical Neoplasms
1
Urinary Bladder Neoplasms
1
Ureteral Neoplasms
1
Tongue Neoplasms
1
Thyroid Neoplasms
1
Thymus Neoplasms
1
Testicular Neoplasms
1
Stomach Neoplasms
1
Skin Neoplasms
1
Sarcoma, Synovial
1
Sarcoma, Kaposi
1
Sarcoma
1
Salivary Gland Neoplasms
1
Rectal Neoplasms
1
Prostatic Neoplasms
1
Primary Myelofibrosis
1
Pheochromocytoma
1
Pharyngeal Neoplasms
1
Penile Neoplasms
1
Parotid Neoplasms
1
Parathyroid Neoplasms
1
Pancreatic Neoplasms
1
Ovarian Neoplasms
1
Interventions
Cyclophosphamide
59
fludarabine phosphate
53
Peripheral Blood Stem Cell Transplantation
43
Tacrolimus
40
Mycophenolic Acid
36
Busulfan
33
Whole-Body Irradiation
32
Antilymphocyte Serum
28
Cyclosporine
27
Methotrexate
25
fludarabine
19
Filgrastim
18
Melphalan
17
Radiotherapy
15
Methylprednisolone
13
Etoposide
12
Cord Blood Stem Cell Transplantation
12
thymoglobulin
11
Sirolimus
11
ruxolitinib
10
Flow Cytometry
10
Psychiatric Rehabilitation
9
Azacitidine
9
Stem Cell Transplantation
7
Granulocyte Colony-Stimulating Factor
7
Decitabine
7
Therapeutics
6
Imatinib Mesylate
6
Cytarabine
6
Cyclosporins
6
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Primary Myelofibrosis
×
Molecular Diagnostic Techniques
×
Other hematologic neoplasm
×
Clear all
NCT02435550
2019-12-20
iCare for Cancer Patients
University of Florida
Phase NA
Terminated
136 enrolled